Nifty Pharma Prediction for Monday, 10 August 2026: Index Eases 0.09 Percent as Sun Pharma and Cipla Profit-Take After Strong Q1 Results Season

The Nifty Pharma prediction for Monday on Monday 10 August 2026 is shaped by Friday's session where Nifty 50 closed at 24,570.65 (down 65 points, -0.27%), Sensex fell 455 points to 78,499.17 and Bank Nifty lost 317 points to 57,746.45. The session's defining paradox: SBI Q1 FY27 beat strongly (PAT +10.23%, NIM recovered to exactly 3 percent, GNPA at a two-decade low of 1.47 percent) but Bajaj Finance crashed 5.84 percent and ICICI Bank fell 2.5 percent, dragging the financial sector. The top performers were Nifty Auto (+1.83 percent), Nifty IT (+1.42 percent led by TCS +3.36 percent) and MCX Gold (+1.40 percent) and MCX Silver (+3.19 percent). The Nifty Pharma is the sectoral index for this prediction for Monday. The primary catalyst for the Nifty Pharma prediction for Monday is the US Non-Farm Payrolls for July 2026, released at 6 PM IST today after Indian market close, which will determine Monday's opening gap direction. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the complete Nifty Pharma prediction for Monday.

Click Here – Get Free Investment Predictions

Friday's Data Behind the Nifty Pharma prediction for Monday

Indicator	Friday 7 Aug Close (Groww Confirmed)	Change
Nifty 50	24,570.65	-65.35 pts (-0.27%)
Sensex	78,499.17	-455.59 pts (-0.58%)
Bank Nifty	57,746.45	-317.20 pts (-0.55%)
Nifty Auto	29,646.95	+1.83%; top sectoral gainer
Nifty IT	31,547.70	+1.42%; TCS +3.36%, HCL +1.62%, Infosys +0.87%
Nifty PSU Bank	8,786.20	+0.65%; SBI +1.12% on Q1 FY27 beat
Nifty Metal	13,189.85	+0.50%; Hindustan Zinc +2.20%
Nifty Private Bank	27,392.35	-1.04%; ICICI -2.50%, Axis -1.43%
SBI Q1 FY27	Rs 1,097.20 (+1.12%)	PAT Rs 21,121 cr (+10.23%); NIM 3.0%; GNPA 1.47% (2-decade low). High: Rs 1,124.5
Bajaj Finance	Rs 1,078 (-5.84%)	Biggest Nifty 50 loser; dragged Fin Services sector
MCX Gold (Aug Fut)	Rs 1,49,703/10g (+1.40%)	Strong surge; safe-haven demand
MCX Silver (Mini Aug)	Rs 2,34,741/kg (+3.19%)	Outperformed gold; industrial + safe-haven combined
MCX Crude Oil (Aug)	Rs 7,356/bbl (-0.28%)	Slight dip; Iran deal uncertainty continues
India VIX	12.16	Unchanged from previous close
US NFP (July 2026)	Released 6 PM IST today	Primary weekend catalyst for Monday gap direction

SBI Q1 FY27 and Bajaj Finance: Two Opposite Forces Behind the Nifty Pharma prediction for Monday

Friday's session presented two contradictory catalysts for the Nifty Pharma prediction for Monday. SBI delivered its strongest quarterly result in recent memory: PAT up 10.23 percent to Rs 21,121 crore, NIM recovered to exactly 3 percent from Q4 FY26's 2.93 percent and GNPA fell to 1.47 percent, a two-decade low. SBI surged to Rs 1,124.5 intraday before closing at Rs 1,097.20 (+1.12 percent). Simultaneously, Bajaj Finance crashed 5.84 percent to Rs 1,078, the biggest Nifty 50 loser, dragging the financial services sector. Ankit Jaiswal notes that the Nifty Pharma prediction for Monday is shaped by which of these two forces dominates on Monday: SBI's confirmed earnings strength or Bajaj Finance's Q1 result-related concerns spilling into the broader NBFC sector.

Technical Levels for the Nifty Pharma prediction for Monday

Level Type	Zone
Immediate Support	26,380-26,420
Key Support	26,080-26,150
Immediate Resistance	26,650-26,750
Key Resistance	26,900-27,050

Kunal Singla observes that India VIX closed Friday at 12.16, unchanged from Thursday's close. Stable VIX at 12-13 despite the broader market fall is structurally positive for the Nifty Pharma prediction for Monday: it means option sellers are not panicking and the August monthly series maintains a defined range. The Nifty Pharma prediction for Monday's support at 26,380-26,420 is the immediate floor heading into Monday.

US NFP: The Nifty Pharma prediction for Monday Primary Weekend Variable

US Non-Farm Payrolls for July 2026 releases at 6 PM IST today. A healthy NFP (175,000-230,000 range) supports a Monday gap-up in this outlook as Dow Jones rises and FII risk-on flows return to India on Monday morning. A weak NFP below 130,000 raises US recession concerns and creates a Monday gap-down in this outlook. Ankit Jaiswal recommends checking GIFT Nifty at 9 AM Monday before making any Nifty Pharma prediction for Monday position decisions.

Key Factors for the Nifty Pharma prediction for Monday

• Nifty Pharma declining only 0.09 percent on a day when Nifty fell 0.27 percent confirms relative outperformance of pharmaceutical stocks. This mild resilience is the primary Nifty Pharma prediction for Monday positive signal.
• Sun Pharma at Rs 1,945 (-0.31 percent Friday) and Cipla at Rs 1,463.80 (-0.89 percent) are in standard post-results profit-booking territory, not structural selling. For the Nifty Pharma prediction for Monday, both stocks have defined accumulation zones.
• Defensive rotation into healthcare is a structural Monday positive for the Nifty Pharma prediction for Monday if broader financial sector concerns from Bajaj Finance continue on Monday.
• US NFP at 6 PM IST today has limited direct impact on the Nifty Pharma prediction for Monday, as the sector is driven by US FDA clearances and India export data rather than US employment figures.

Stocks to Watch for the Nifty Pharma prediction for Monday

Univest analysts flag the following stocks for educational observation in this outlook on Monday. These are not buy or sell recommendations.

Sun Pharma: CMP Rs 1,945 (-0.31% Fri). Ankit Jaiswal flags entry Rs 1,925-1,942, target Rs 1,992, SL Rs 1,896. Sun Pharma is the Nifty Pharma prediction for Monday's primary stock. Rs 1,925-1,942 is the accumulation zone after Friday's mild -0.31 percent dip.

Cipla: CMP Rs 1,463.80 (-0.89% Fri). Kunal Singla flags entry Rs 1,454-1,462, target Rs 1,498, SL Rs 1,428. Cipla at Rs 1,463 approaching support after -0.89 percent Friday creates an accumulation opportunity in this outlook.

Divi's Laboratories: CMP Rs 8,275 (-0.89% Fri). Ankit Jaiswal flags entry Rs 8,200-8,260, target Rs 8,430, SL Rs 8,080. Divi's Labs at Rs 8,275 (-0.89 percent Friday) is in this outlook accumulation zone with CRAMS growth visibility.

Screen All Stocks for the Nifty Pharma prediction for Monday on Univest

Trading Strategy for the Nifty Pharma prediction for Monday

1. 26,380-26,420 is the support for the Nifty Pharma prediction for Monday.
2. 26,650-26,750 is the first resistance in this outlook.
3. Track Sun Pharma above Rs 1,940 on Monday as the Nifty Pharma prediction for Monday benchmark.
4. Defensive rotation from financial sector to pharma on continued Bajaj Finance concerns would support the Nifty Pharma prediction for Monday.

Risks to the Nifty Pharma prediction for Monday

• US FDA warning letters on Indian pharma manufacturing facilities creating sector headwinds in this outlook.
• Divi's Labs extending Friday's -0.89 percent on continuation selling in this outlook.
• Risk-on rally from strong NFP reducing defensive pharmaceutical allocation in this outlook.

Conclusion

The Nifty Pharma prediction for Monday on Monday 10 August 2026 is built on Friday's close of 26,541.80 (-0.09% (-23 pts)), from a session where Nifty Auto (+1.83 percent), Nifty IT (+1.42 percent) and MCX precious metals (Gold +1.40 percent, Silver +3.19 percent) were the week's bright spots while Bajaj Finance (-5.84 percent) and ICICI Bank (-2.5 percent) created financial sector drag. Ankit Jaiswal of Univest identifies 26,650-26,750 as the primary resistance and 26,380-26,420 as the critical support for the Nifty Pharma prediction for Monday. The US NFP at 6 PM IST today is the primary variable: monitor GIFT Nifty Sunday evening and at 9 AM Monday before positioning for the Nifty Pharma prediction for Monday.

Kunal Singla of Univest notes that the Nifty Pharma prediction for Monday has a dual structure for Monday: the recovery case (IT and Auto momentum continues, SBI Q1 beat sustains, NFP healthy) and the continuation decline case (Bajaj Finance concerns spread to NBFCs, private banks extend selling, weak NFP). The Nifty Pharma prediction for Monday's support zone at 26,380-26,420 is the line between these two scenarios on Monday.

Download the Univest iOS App or Univest Android App to track live levels and receive NFP-driven alerts for the Nifty Pharma prediction for Monday on Monday.

FAQs on Nifty Pharma Prediction For Monday, 10 August 2026

What is the Nifty Pharma prediction for Monday, 10 August 2026?

Ans. The Nifty Pharma prediction for Monday is neutral. Nifty Pharma eased 0.09 percent to 26,541.80 on Friday, mildly outperforming the broader Nifty (-0.27 percent). Support is 26,380-26,420 and resistance is 26,650-26,750 in this outlook.

Which analysts prepared the Nifty Pharma prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the Nifty Pharma prediction for Monday using Groww-confirmed data: Nifty Pharma 26,541.80 (-0.09%), Sun Pharma Rs 1,945 (-0.31%), Cipla Rs 1,463.80 (-0.89%).

Is Friday's Nifty Pharma decline a concern for the prediction for Monday?

Ans. No. The 0.09 percent Nifty Pharma decline on Friday, when Nifty fell 0.27 percent, confirms relative outperformance. The mild selling in Sun Pharma and Cipla is profit-booking after strong Q1 results, not a structural reversal in the Nifty Pharma prediction for Monday.

What is Nifty Pharma support and resistance for the prediction for Monday?

Ans. Support is 26,380-26,420 and 26,080-26,150. Resistance is 26,650-26,750 and 26,900-27,050 in the Nifty Pharma prediction for Monday.

What stocks are watched in the Nifty Pharma prediction for Monday?

Ans. Sun Pharma (accumulation at Rs 1,925-1,942), Cipla (support at Rs 1,454-1,462) and Divi's Laboratories (CRAMS growth at Rs 8,200-8,260 support) are the three stocks in the Nifty Pharma prediction for Monday.